Ansana is developing and marketing a sterilisation technology for the healthcare and pharmaceutical sectors.
Ansana has raised €1.5M across 1 funding round from 4 investors, most recently a Seed round in Sep 2025. Based in Maastricht, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-30 | Seed | €1.5M |
| BGO Ventures,Healthliant Ventures,NLC Health Ventures,Private Investors |
| View deal → |
